10-K: USANA Reports 74% Earnings Drop Amid Core Business Decline

USANA Health Sciences, Inc. reported a significant 74.4% decrease in net earnings for fiscal year 2025, despite an 8.3% increase in net sales driven by the Hiya acquisition, as its core nutritional business experienced a 14.8% decline in active customers.

Summary

• Net sales increased by 8.3% to $925.3 million in 2025, primarily due to the full-year inclusion of Hiya Health Products, LLC sales of $130.0 million.
• Net earnings attributable to USANA decreased by 74.4% to $10.8 million in 2025, down from $42.0 million in 2024.
• Diluted earnings per share (EPS) attributable to USANA fell to $0.58 in 2025 from $2.19 in 2024.
• The core nutritional business experienced an 8.3% decline in net sales and a 14.8% decrease in active customers, totaling 387,000 worldwide.
• Gross profit decreased by 280 basis points to 78.3% of net sales, largely due to the lower gross margins of the acquired Hiya segment.
• Operating expenses included a one-time charge of $6.463 million for cost realignment and a non-cash goodwill impairment charge of $6.527 million in the fourth quarter of 2025.
• The effective tax rate significantly increased to 72.4% of pre-tax earnings in 2025, up from 44.9% in 2024, driven by lower U.S. earnings and a relatively similar amount of foreign taxes.
• Cash and cash equivalents decreased to $158.4 million at January 3, 2026, from $181.8 million at December 28, 2024.
• The company repurchased and retired 927 shares for $27.7 million in 2025, with $34.0 million remaining authorized under the share repurchase plan.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing with a negative sentiment due to the sharp decline in net earnings and EPS, coupled with a significant drop in active customers in the core business. While acquisitions offer diversification, the underlying performance of the traditional segment and high tax rate are concerning.

Positives

• The acquisition of Hiya Health Products, LLC significantly diversified the company's growth into the direct-to-consumer channel, contributing $130.0 million in incremental sales in 2025.
• Hiya's subscription model is expected to provide a steady, predictable income stream and foster stronger customer relationships, leading to retention and loyalty.
• The company is expanding Hiya's distribution into online marketplaces and select retail partners, and geographically into Canada and the United Kingdom in early 2026.
• USANA is leveraging its in-house manufacturing capabilities to produce Hiya products, expecting savings and efficiencies of scale starting in the second half of 2026.
• The company successfully remediated material weaknesses in internal control over financial reporting identified in 2024, concluding controls were effective as of January 3, 2026.
• Enhancements to the Brand Partner Compensation Plan were rolled out in Q3 2025 to strengthen competitiveness and appeal, aiming to drive sustainable income and reward sales/customer growth.
• Continued investment in research and development (R&D) led to over 15 new or upgraded product launches in 2025, with plans for further investment in 2026 to advance cellular nutrition expertise.

Negatives

• Net earnings attributable to USANA decreased by a substantial 74.4% in 2025 compared to 2024.
• Diluted earnings per share (EPS) dropped significantly from $2.19 in 2024 to $0.58 in 2025.
• The core nutritional business experienced an 8.3% decline in net sales and a 14.8% decrease in active customers, indicating challenges in its primary segment.
• Gross profit margin decreased by 280 basis points, partly due to the inclusion of Hiya, which has lower gross margins.
• The effective tax rate increased sharply to 72.4% in 2025, primarily due to lower U.S. earnings before taxes and cost realignment/impairment charges.
• The company incurred a one-time charge of $6.463 million for cost realignment and a non-cash goodwill impairment charge of $6.527 million in Q4 2025.
• Cash and cash equivalents decreased by $23.4 million from the prior year, with net cash provided by operating activities significantly lower at $22.3 million compared to $61.0 million in 2024.
• Product returns slightly increased to 0.8% of net sales in 2025 from 0.6% in prior years.

Risks

• Direct selling is subject to intense government scrutiny and regulation, and changes in laws or their interpretation could adversely affect the business.
• Violations of marketing or advertising laws by Brand Partners or improper promotion of the Compensation Plan could lead to legal action and increased regulatory scrutiny.
• The company may incur obligations related to Brand Partner activities, including potential reclassification of Brand Partners as employees, which could increase costs.
• Changes to the Brand Partner Compensation Plan may be viewed negatively by some Brand Partners, fail to achieve objectives, or lead to legal challenges.
• The Greater China region, a significant part of the business, is subject to substantial government regulation, legal, political, and economic risks, and a decline in sales or customers there would harm operations.
• The Chinese government has not approved BabyCare's business model, compensation plan, and operations, posing a risk of fines, penalties, or suspension of business.
• BabyCare must obtain government approval to expand its business in China, and failure to do so could negatively impact growth.
• Operating in international markets exposes the company to instability, regulatory changes, currency fluctuations, and political/economic conditions.
• Trade policies, disputes, tariffs, or other international disputes, particularly between the U.S. and China, could harm business and operating results.
• Inflationary pressures, high raw material prices, and instability in logistics costs could negatively impact profitability.
• Products and manufacturing activities are subject to extensive government regulation, and non-compliance could limit or prevent sales.
• In-house manufacturing is subject to risks like power failures, equipment breakdown, natural disasters, and compliance with government agency requirements.
• Reliance on third parties for manufacturing and supply of certain products (44% of sales in 2025) carries risks of unreliable supply, quality issues, and production delays.
• Inability to obtain adequate supplies of raw materials at favorable prices could lead to product shortages and negatively impact gross margins.
• Delays and disruptions in transporting and distributing products, including increased costs and capacity issues, may adversely affect results.
• The company could incur product liability claims and litigation, despite maintaining insurance.
• Nutritional supplement products may be supported by only limited conclusive clinical studies, and adverse publicity regarding efficacy or safety could harm the business.
• Legal action by former Brand Partners or third parties, including class action litigation, could result in fines, damages, and adverse publicity.
• Potential liability under the Athlete Guarantee program if an athlete tests positive for a banned substance due to USANA products.
• Failure to comply with anti-corruption laws, such as the FCPA, could lead to severe criminal or civil penalties and reputational harm.
• Adverse changes in tax laws, regulations, or interpretations, or challenges to tax positions, could increase the effective tax rate and reduce profitability.
• Failure to maintain an effective system of internal controls could lead to inaccurate financial reporting or fraud.
• Inability to meet sustainability goals or evolving ESG expectations could harm reputation and consumer demand.
• A failure or interruption of information technology systems, including data breaches or cybersecurity attacks, would harm the business and expose the company to liability.
• Non-compliance with data privacy and security laws and regulations could result in enforcement actions, fines, and reputational damage.
• Inability to attract and retain active Brand Partners and Preferred Customers, or the loss of key Brand Partner leaders, could harm the business.
• The loss of key management personnel could adversely affect the business.
• Acquisition-related risks include integration challenges, failure to realize anticipated benefits, loss of key employees/customers, and unanticipated liabilities.
• The Hiya acquisition may not be accretive and could be dilutive to EPS, and its integration may result in additional costs.
• The Hiya acquisition and expansion into new businesses may be viewed negatively by some Brand Partners, potentially impacting their productivity.
• Hiya's ability to acquire customers cost-effectively depends on adapting to changes in the digital marketing environment, including social media algorithms and data privacy laws.
• Rise's business depends on a limited number of key retail customers, and the loss or reduction of orders from them could materially adversely affect its business.
• Difficult economic conditions may adversely affect demand for products, profitability, and cash flow.
• Adverse publicity or negative public perception regarding the industry, products, or business practices could harm the company's reputation and sales.
• Intense competition from larger, wealthier, and more established competitors, and the ease of entry for new competitors, pose a risk.
• Most products are not protected by patents, and efforts to protect trade secrets and trademarks may not be successful, leading to potential infringement claims.
• Public health crises could disrupt business, supply chains, manufacturing, and sales activities.
• The beneficial ownership of 40.0% of common stock by the founder limits the influence of other shareholders and could delay/prevent a change in control.
• Sales by principal shareholders of large amounts of stock could adversely affect the market price.
• The market price of common stock may be influenced by many factors beyond control, including volatility from short positions and failure to meet analyst expectations.

Future Outlook

The company plans to continue supporting and growing its acquired businesses, Hiya and Rise, through product portfolio expansion, distribution channel expansion (online marketplaces, retail), and geographic expansion into Canada and the United Kingdom for Hiya in early 2026. It intends to accelerate technology initiatives to modernize core systems, improve customer experience, and increase AI adoption. The core nutritional business will focus on enhancing Brand Partner earning opportunities, accelerating new product launches, strengthening brand messaging, deepening Brand Partner engagement, and implementing tailored regional strategies, particularly in China and India. The company also expects to continue pursuing strategic acquisition opportunities in the health and wellness space.

Management Comments

• "We are leveraging our strong foundation in the nutrition business and expanding beyond our legacy direct selling channel to connect with a greater number of health-conscious consumers worldwide."
• "By deepening consumer engagement, empowering our Brand Partners, and executing with discipline, we believe we can accelerate profitable growth, extend our competitive advantages, and deliver sustainable long-term value for our shareholders."
• "Our product teams will continue working to roll out these recently launched products to all of our markets globally over the next several quarters."
• "In 2026, our commercial team will remain actively engaged in prioritizing in-person meetings with our Brand Partners, with a focus on training and education, to ensure these recent product launches and Compensation Plan enhancements are successful and fully leveraged by our global active Brand Partners."
• "We expect to continue investing in R&D to advance our expertise and leadership in cellular nutrition, as well as overall health and wellness."
• "We believe our current liquidity, through cash flow from operations along with our line of credit, is adequate to meet our cash requirements and sustain our operations."
• "Maintaining a capital structure that emphasizes sufficient liquidity and adaptability in the prevailing economic climate is our top priority."

Industry Context

StockSavvy.ai notes that USANA's strategic shift towards an omni-channel platform, incorporating direct-to-consumer and retail alongside its traditional direct selling model, reflects a broader industry trend among health and wellness companies seeking diversified revenue streams and wider market reach. The significant decline in its core direct selling active customer base, particularly in key markets like China, highlights the increasing challenges and regulatory scrutiny faced by the multi-level marketing industry globally. Competitors like Herbalife and Nu Skin also navigate similar regulatory environments and evolving consumer preferences, making USANA's ability to effectively integrate its acquisitions and adapt its marketing strategies crucial for competitive positioning.

Comparison to Industry Standards

• The decline in USANA's core nutritional active customer base by 14.8% is a notable underperformance compared to some direct selling peers who have managed to stabilize or achieve modest growth in their distributor/customer networks in certain regions.
• The significant increase in USANA's effective tax rate to 72.4% is substantially higher than the average corporate tax rates seen in the health and wellness industry, which typically range from 20-30% for profitable companies, indicating a severe geographic misalignment of income and expenses.
• The gross profit margin of 78.3% for USANA remains strong, particularly in its core nutritional segment, which is competitive with high-margin supplement companies, though the inclusion of Hiya's lower margins has diluted the consolidated figure.
• USANA's R&D expenditure of $10.7 million in 2025, while a slight decrease from prior years, demonstrates a continued commitment to product innovation, which is a key differentiator in the competitive nutritional supplement market, comparable to R&D efforts by science-focused peers.

Management Changes

Corporate Governance

Legal Proceedings

• The company is involved in various lawsuits, claims, and other legal matters that arise in the ordinary course of business, including matters involving products, intellectual property, supplier relationships, distributors, competitor relationships, and employees.
• Management does not currently believe that any of these matters, individually or in the aggregate, will have a material adverse effect on the company's financial condition, liquidity, or results of operations.
• The company has been involved in litigation with Brand Partners whose purchase and distribution rights were terminated, including a private lawsuit in California seeking to reclassify Brand Partners as employees (which the company prevailed in).
• The FTC sent warning letters to the company in 2021 and 2023 regarding potential penalties for unfair, deceptive, or unlawful conduct and failure to adequately substantiate product claims, though no unlawful conduct was accused.
• The FTC issued a Notice of Proposed Rulemaking (NPR) and an Advanced Notice of Proposed Rulemaking (ANPR) in 2025 regarding potential rules for earnings claims for direct selling companies, which could impose additional restrictions.

Related Party Transactions

• Gull Global, Ltd., an entity solely owned and controlled by the company's founder, Dr. Myron Wentz, owned approximately 40.0% of the outstanding common stock as of January 3, 2026, allowing it to exert significant influence over board elections and business affairs.

Stakeholder Impact

• **Shareholders**: Negative impact due to significant decline in net earnings and EPS, increased effective tax rate, and goodwill impairment. Potential for dilution if future capital raises involve equity. Founder's significant ownership limits influence of other shareholders.
• **Brand Partners**: Impacted by changes to the Compensation Plan, which aims to enhance earning opportunities but may be viewed negatively by some. Decline in active customers suggests challenges in recruitment and retention. Increased training and engagement initiatives are positive for their business development.
• **Customers**: Benefit from continuous product innovation, new product launches, and an expanding omni-channel platform (Hiya, Rise) offering more diverse health and wellness products. Hiya's subscription model aims to improve retention and loyalty.
• **Employees**: Affected by cost realignment and rightsizing processes, which resulted in a one-time charge primarily related to employee severance. The company emphasizes talent management, development, health, safety, and inclusion programs.
• **Suppliers**: Potential impact from supply chain disruptions, raw material price increases, and the company's efforts to increase in-house manufacturing, which could reduce reliance on third-party suppliers over time.
• **Creditors**: The company maintains a credit facility with $14.0 million outstanding, and its ability to meet debt covenants is a factor. Decreased operating cash flow could be a concern, though current liquidity is deemed adequate.

Next Steps

• Continue to promote and train Brand Partners on Compensation Plan enhancements during 2026.
• Develop, promote, and deploy marketing and training materials for new products and Compensation Plan enhancements.
• Commercial team to prioritize in-person meetings with Brand Partners for training and education in 2026.
• Strengthen content creation at regional and local levels to enhance Brand Partner recruitment and customer attraction.
• Continue executing global strategy to increase active Customers in each market.
• Accelerate the launch of new and upgraded products and drive innovative product development.
• Enhance and refine brand messaging to create a more compelling and consistent market presence.
• Deepen engagement with Brand Partners through in-person and digital initiatives.
• Focus on China with tailored, decentralized solutions, including digital customer acquisition, enhanced digital capabilities, and market-leading training programs.
• Expand product portfolio with products specifically designed for the Chinese consumer.
• Strengthen regional approach by empowering local leaders with greater authority over product development and incentive creation.
• Continue executing long-term growth strategy in India by expanding product portfolio, strengthening local marketing, and supporting Brand Partners.
• Evaluate new international markets for potential expansion.
• Continue to support and grow Hiya and Rise through product portfolio expansion, distribution channel expansion (online marketplaces, retail), and geographic expansion (Canada and UK for Hiya in early 2026, retail for Hiya in Q2 2026).
• Transition production of powdered drink mixes and various Hiya products to USANA facilities in 2026 to generate savings.
• Continue to pursue acquisition opportunities in the health and wellness space focusing on nutrition, vertical integration, product/category expansion, distribution channel expansion, and geographic expansion.
• Accelerate technology initiatives to modernize core systems and improve customer experience.
• Strategically leverage leading third-party IT platforms to move faster and more efficiently.
• Invest in strengthening data foundation to improve internal reporting and enable AI/machine learning projects.
• Increase artificial intelligence adoption to speed up internal work and efficiency.
• The Sustainability Committee of the Board of Directors will continue to oversee and advise on corporate sustainability matters.
• Continue to incorporate and advance sustainability-related principles and practices across all markets.

Key Dates

Recommendation

The significant decline in net earnings and EPS, coupled with a substantial decrease in active customers in the core nutritional business, presents a negative outlook. However, the strategic acquisitions of Hiya and Rise, and the pivot to an omni-channel distribution model, offer potential for future diversification and growth. The remediation of internal control weaknesses is a positive governance step. Given the mixed signals—strong strategic moves offset by poor financial performance in the core business and high tax rates—a 'hold' recommendation is appropriate. Investors should monitor the integration of acquisitions, the effectiveness of new growth strategies, and the stabilization of the core direct selling segment before making further investment decisions.

Keywords

Nutritional Supplements, Direct Selling, Health and Wellness, Multi-level Marketing, Dietary Supplements, Personal Care Products, Functional Foods, Hiya Health, Rise Bar, Omni-channel Retail, SEC Filing, 10-K, USANA, USNA